Publicaciones en colaboración con investigadoras/es de Hospital de la Santa Creu i Sant Pau (31)

2024

  1. Correction in article by Juzga-Corrales et al. “Characteristics and outcomes of the Spanish registry for pediatric patients with bicuspid aortic valve (REVAB)”, Rev Esp Cardiol. 2023;76:961-969 (Revista Española de Cardiología (English Edition) (2024) 77(4) (358–359), (S1885585724000331), (10.1016/j.rec.2023.12.011))

    Revista Espanola de Cardiologia

2023

  1. Alpha-1 antitrypsin deficiency and Pi*S and Pi*Z SERPINA1 variants are associated with asthma exacerbations

    Pulmonology

  2. Characteristics and outcomes of the Spanish registry for pediatric patients with bicuspid aortic valve (REVAB)

    Revista Espanola de Cardiologia, Vol. 76, Núm. 12, pp. 961-969

  3. GEMA 5.3. Spanish Guideline on the Management of Asthma

    Open Respiratory Archives, Vol. 5, Núm. 4

2022

  1. Langerhans cell histiocytosis. Advances in pathogenesis and clinical practice

    Anales de Pediatria, Vol. 97, Núm. 2, pp. 130.e1-130.e7

  2. Multi-ancestry genome-wide association study of asthma exacerbations

    Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology, Vol. 33, Núm. 6, pp. e13802

  3. Neuroblastoma in Spain: Linking the national clinical database and epidemiological registries – A study by the Joint Action on Rare Cancers

    Cancer Epidemiology, Vol. 78

  4. Spanish Asthma Management Guidelines (GEMA) VERSION 5.1. Highlights and Controversies

    Archivos de Bronconeumologia

2021

  1. Collaborative model for diagnosis and treatment of very rare diseases: experience in Spain with thymidine kinase 2 deficiency

    Orphanet Journal of Rare Diseases, Vol. 16, Núm. 1

  2. GEMA5.0 - SPANISH GUIDELINE ON THE MANAGEMENT OF ASTHMA

    Journal of investigational allergology & clinical immunology, Vol. 31, Núm. GEMA 50, pp. 1-130

  3. Highlights of the Spanish Asthma Guidelines (GEMA), version 5.0

    Archivos de Bronconeumologia

  4. Improved collection of hematopoietic stem cells and progenitors from Fanconi anemia patients for gene therapy purposes

    Molecular Therapy - Methods and Clinical Development, Vol. 22, pp. 66-75

2020

  1. Discrepancies Between GEMA and GINA in the Classification of Inhaled Corticosteroids

    Archivos de Bronconeumologia

  2. Distinct molecular profile of IRF4-rearranged large B-cell lymphoma

    Blood, Vol. 135, Núm. 4, pp. 274-286

  3. Initial report on Spanish pediatric oncologic, hematologic, and post stem cell transplantation patients during SARS-CoV-2 pandemic

    Pediatric Blood and Cancer

2019

  1. Successful engraftment of gene-corrected hematopoietic stem cells in non-conditioned patients with Fanconi anemia

    Nature Medicine, Vol. 25, Núm. 9, pp. 1396-1401

2017

  1. Down syndrome as risk factor for respiratory syncytial virus hospitalization: A prospective multicenter epidemiological study

    Influenza and other Respiratory Viruses, Vol. 11, Núm. 2, pp. 157-164

2016

  1. El Registro Molecular de Adenomas Hipofisarios (REMAH): una apuesta de futuro de la Endocrinología española por la medicina individualizada y la investigación traslacional

    Endocrinología y nutrición: órgano de la Sociedad Española de Endocrinología y Nutrición, Vol. 63, Núm. 6, pp. 274-284

  2. GEMA 4.0 Spanish guidelines of the management of Asthma

    Journal of Investigational Allergology and Clinical Immunology

2013

  1. Risk factors and effectiveness of preventive measures against influenza in the community

    Influenza and other Respiratory Viruses, Vol. 7, Núm. 2, pp. 177-183